←
Tyler Pitre, MD PhD🇨🇦1,227 posts
Tyler Pitre, MD PhD🇨🇦 avatar

Tyler Pitre, MD PhD🇨🇦

@TylerSC10

🇨🇦Canadian I Respirologist🫁| PH-ILD Doctor @uhn| Alumnus @UNB @WesternU @mcmasterU @uniofeastanglia. Founder of coreSR.ai.

◷ Joined September 2019▧ 114 Photos and videos
CoreSR avatar
⟳ Tyler Pitre, MD PhD🇨🇦 retweeted
CoreSR@CoreSRR·Oct 25

Launching SynthesisBench: an open screening benchmark across 85 systematic reviews, 2,327 records and 26 systems. Top Youden's J: TITAN-SR v6 0.879, Claude Opus 5.5 0.831, GLASS-SR 0.827. Run by CoreSR. synthero.ai/screening

Post attachment
CoreSR avatar
⟳ Tyler Pitre, MD PhD🇨🇦 retweeted
CoreSR@CoreSRR·Oct 20

New CoreSR models: TITAN-SR v6 screens, GLASS v3 appraises with quotes from the paper, ROB BERT v6 fills in RoB 2 while a second model checks it. On 60 held-out reviews, TITAN kept 932 of 933 includes and screened out 78% of the rest. youtu.be/uTbnVkTiOnE

CoreSR avatar
⟳ Tyler Pitre, MD PhD🇨🇦 retweeted
CoreSR@CoreSRR·Oct 4

Which AI should screen 10,000 abstracts? Chatbots write one word at a time. BERT reads both ways and gives a score you can tune for high recall. TITAN-SR kept 99.8% of included studies in 22 later Cochrane reviews. sciencedirect.com/science/ar… coresr.ai #SystematicReview #Epi

0:37
Tyler Pitre, MD PhD🇨🇦 avatar
Tyler Pitre, MD PhD🇨🇦@TylerSC10·Oct 1

Result: no survival benefit from pulse dosing. 28-day mortality 10.0% vs 14.6% (P=0.55) 90-day mortality 24.5% vs 29.8% (P=0.65) Wide CIs, and secondary outcomes (ICU, ventilation/ECMO, adverse events) didn't differ either. 4/5

Tyler Pitre, MD PhD🇨🇦 avatar
Tyler Pitre, MD PhD🇨🇦@TylerSC10·Oct 1

Design: open-label RCT, 8 South Korean university hospitals, 100 adults with AE-IPF (51 pulse, 49 non-pulse). Pulse: methylpred 10 mg/kg x 3 days Non-pulse: 1 mg/kg x 7 days Both then got a protocolized taper to low-dose prednisolone. 3/5

Tyler Pitre, MD PhD🇨🇦 avatar
Tyler Pitre, MD PhD🇨🇦@TylerSC10·Oct 1

Why it matters: AE-IPF has high short-term mortality. Guidelines only weakly recommend steroids and don't define dose or duration, yet pulse methylprednisolone is widely used on thin evidence. 2/5

Tyler Pitre, MD PhD🇨🇦 avatar
Tyler Pitre, MD PhD🇨🇦@TylerSC10·Sep 30

Not all ILA progresses. Can CT AI flag who will? COPDGene+AGES: MIL-UIP. Score>0.5 → ~13–14%/yr fibrosis↑; death HR~1.6 both cohorts. Takeaway: automated UIP-like CT may risk-stratify ILA. Caveat: observational; needs validation. #ILD #IPF #PulmTwitter doi.org/10.1093/ajrccm/aamag…